Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Iacobaeus

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Therapeutic Advances in Neurological Disorders|January 31, 2022
Smouldering multiple sclerosis: the 'real MS'Gavin Giovannoni, Veronica Popescu, Jens Wuerfel, et al.
Brain : a Journal of Neurology|September 24, 2025
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosisRoberto Furlan, Sabine Schaedelin, Jette Lautrup Frederiksen, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 23, 2013
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosisCharlotte Teunissen, Til Menge, Ayse Altintas, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysisAhmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Therapeutic Advances in Neurological Disorders|January 31, 2022
Smouldering multiple sclerosis: the 'real MS'Gavin Giovannoni, Veronica Popescu, Jens Wuerfel, et al.
Brain : a Journal of Neurology|September 24, 2025
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosisRoberto Furlan, Sabine Schaedelin, Jette Lautrup Frederiksen, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 23, 2013
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosisCharlotte Teunissen, Til Menge, Ayse Altintas, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysisAhmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.
Pageof 4